Kidney Care Partners calls for a legislative and regulatory overhaul of renal disease treatment, including changes to the Medicare end-stage renal disease prospective payment system, an expansion of the Medicare Kidney Disease Education benefit, an extension of Medigap access for those with kidney disease and an HHS study on the social, behavioral and biological factors that lead to the disease. “We’re confident that the goals laid out in Kidney Care First – after more than a year of development...